๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impairment of retrograde axonal transport in wobbler mouse motor neuron disease

โœ Scribed by Dr. Hiroshi Mitsumoto; Ms. Anita L. Ferut; Dr. Kozo Kurahashi; Dr. Irvine G. McQuarrie


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
509 KB
Volume
13
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

โœฆ Synopsis


The earliest horseradish peroxidase (HRP) neuronal labeling (the fastest retrograde transport) was determined by histochemical techniques at various intervals after intramuscular HRP injection in wobbler mice and normal littermates. In the clinically impaired forelimb system, the retrograde transport rate was 150-170 mm/day in wobbler mice and 170-230 mm/day in controls. However, there was no statistical difference between the two groups. The neuronal HRP accumulation at the early intervals was significantly less in wobbler mice than controls, suggesting that the amount of HRP transport was diminished in each axon. For the clinically intact hindlimb nerves, the rate was normal in wobbler mice, but the amount of neuronal HRP was significantly increased. Retrograde axonal transport appeared to be affected in a differential fashion, depending on the extent of disease.


๐Ÿ“œ SIMILAR VOLUMES


Defective axonal transport in motor neur
โœ Ali Morsi El-Kadi; Violetta Soura; Majid Hafezparast ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 359 KB

## Abstract Several recent studies have highlighted the role of axonal transport in the pathogenesis of motor neuron diseases. Mutations in genes that control microtubule regulation and dynamics have been shown to cause motor neuron degeneration in mice and in a form of human motor neuron disease.

Histometric effects of ciliary neurotrop
โœ Ken Ikeda; Vivien Wong; Thomas H. Holmlund; Tom Greene; Jesse M. Cedarbaum; Rona ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 858 KB

We investigated the histological effects of ciliary neurotrophic factor on degenerating motor neurons, their axons, and skeletal muscles in 68 wobbler mice with motor neuron disease. Treatment consisted of recombinant rat or human ciliary neurotrophic factor (or a vehicle solution), 1-mg/kg subcutan